Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Udagawa

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 11, 2000
Schnurri interacts with Mad in a Dpp-dependent mannerY Udagawa, J Hanai, K Tada, et al.
Nihon Sanka Fujinka Gakkai Zasshi|January 1, 1984
[Modulation of alkaline phosphatase by butyrate and prednisolone in uterine cervical cancer cell line (SKG-III)]S Nozawa, D Tsai, M Kojima, et al.
Human Molecular Genetics|May 20, 1999
PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survivalM Waragai, C H Lammers, S Takeuchi, et al.
Nihon Sanka Fujinka Gakkai Zasshi|November 1, 1989
[The evaluation of CA54/61 in the diagnosis of ovarian cancer--with special reference to the cooperative results of 5 institutes]S Nozawa, M Yajima, Y Udagawa, et al.
Journal of Clinical Laboratory Analysis|January 1, 1992
Specificity of a tumor marker (CA54/61) and its individual epitopes recognized by monoclonal antibodies, MA54 and MA61, in human tumor patientsH Mochizuki, K Nagoya, T Yamauchi, et al.
Molecular Biology of the Cell|August 7, 1998
Interplay of signal mediators of decapentaplegic (Dpp): molecular characterization of mothers against dpp, Medea, and daughters against dppH Inoue, T Imamura, Y Ishidou, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1992
[A study of preclinical and clinical usefulness of new tumor markers of ovarian carcinoma, CA 54/61 and CA 602. 1. Evaluation of the diagnostic accuracy of CA 54/61, a study of the normal range of its values and its correlation with other tumor markers]S Nozawa, Y Udagawa, H Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers]S Nozawa, Y Udagawa, H Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1994
[Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases]S Nozawa, Y Udagawa, H Sasaki, et al.
The Journal of Pathology|December 1, 1987
Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor statusC Wright, B Angus, J Napier, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|July 11, 2000
Schnurri interacts with Mad in a Dpp-dependent mannerY Udagawa, J Hanai, K Tada, et al.
Nihon Sanka Fujinka Gakkai Zasshi|January 1, 1984
[Modulation of alkaline phosphatase by butyrate and prednisolone in uterine cervical cancer cell line (SKG-III)]S Nozawa, D Tsai, M Kojima, et al.
Human Molecular Genetics|May 20, 1999
PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survivalM Waragai, C H Lammers, S Takeuchi, et al.
Nihon Sanka Fujinka Gakkai Zasshi|November 1, 1989
[The evaluation of CA54/61 in the diagnosis of ovarian cancer--with special reference to the cooperative results of 5 institutes]S Nozawa, M Yajima, Y Udagawa, et al.
Journal of Clinical Laboratory Analysis|January 1, 1992
Specificity of a tumor marker (CA54/61) and its individual epitopes recognized by monoclonal antibodies, MA54 and MA61, in human tumor patientsH Mochizuki, K Nagoya, T Yamauchi, et al.
Molecular Biology of the Cell|August 7, 1998
Interplay of signal mediators of decapentaplegic (Dpp): molecular characterization of mothers against dpp, Medea, and daughters against dppH Inoue, T Imamura, Y Ishidou, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1992
[A study of preclinical and clinical usefulness of new tumor markers of ovarian carcinoma, CA 54/61 and CA 602. 1. Evaluation of the diagnostic accuracy of CA 54/61, a study of the normal range of its values and its correlation with other tumor markers]S Nozawa, Y Udagawa, H Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1992
[Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers]S Nozawa, Y Udagawa, H Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1994
[Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases]S Nozawa, Y Udagawa, H Sasaki, et al.
The Journal of Pathology|December 1, 1987
Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor statusC Wright, B Angus, J Napier, et al.
Pageof 8